Table 2.
Induction Method | Stimulation Protocol | Duration | Model | Sex | Age (Months) | Modulated AD Phenotype | Reference | |
---|---|---|---|---|---|---|---|---|
Invasive | Optogenetic | 1 ms pulses, 40 Hz, CA1 | 1 h | 5xFAD::PV-Cre, AAV5-EF1α-DIO-ChR2-eYFP | M | 3 | Reduced Aβ Reduced inflammation |
[89] |
12 ms pulses, 40 Hz, Medial Septum | 10 min | PVJ20, AAVdj-EF1α-DIO-ChETA-eYFP | M/F | NA | Improved spatial memory | [88] | ||
40 Hz, Basal Forebrain | 1 h/d for 3 days | 5xFAD::PV-Cre::Ai32 | M/F | 4–6 | Increased Aβ | [157] | ||
Non-Invasive | Visual | 12.5 ms on, 12.5 ms off, 40 Hz flicker | 1 h/day for 7 days | 5xFAD | M | 6 | Reduced Aβ | [89] |
APP/PS1 | M/F | 5 | Reduced Aβ | |||||
TauP301S | M | 4 | Reduced tauopathy | |||||
40 Hz flicker | 1 h/day for 30 days | APP/PS1 | F | 8 | Reduced Aβ Reduced tauopathy Increased sleep regulation |
[160] | ||
12.5 ms on, 12.5 ms off, 40 Hz flicker | 1 h/day for 22 days | TauP301S | M | 7.5–8 | Reduced neuronal damage Reduced inflammation Reduced tauopathy Improved spatial memory |
[91] | ||
1 h/day for 6 weeks | CK-p25 | M/F | 6–9 | Reduced neuronal damage Reduced inflammation Improved spatial memory |
||||
Auditory | 1 ms 10 kHz tones, 40 Hz, 60 dB | 1 h/day for 7 days | 5xFAD | NA | 6 | Reduced Aβ Reduced inflammation Improved memory |
[90] | |
APP/PS1 | NA | 6–9 | Reduced Aβ Reduced inflammation |
|||||
TauP301S | NA | 2 | Reduced tauopathy | |||||
Combined Auditory and Visual | 10 s on, 10 s off | 1 h/day for 7 days | 5xFAD | NA | 6 | Reduced Aβ Reduced inflammation |
||
Visual and Exercise | 40 Hz light flicker and 30–50 min exercise | Daily, 6 days a week for 12 weeks | 3xTg | M | 12–15 | Reduced Aβ Reduced tauopathy Reduced neuronal damage Improved spatial memory |
[159] | |
Transcranial Focused Ultrasound | 400 μs pulses, 5 s on 5 s off, 40 Hz, Hippocampus | 1 h/day for 5 days | 5xFAD | M | 6 | Increased microglia/Aβ Co-localisation | [158] |